Biphenyl Sulfonamide Compounds For The Treatment Of Type Iv Collagen Diseases

Patent No. EP3860594 (titled "Biphenyl Sulfonamide Compounds For The Treatment Of Type Iv Collagen Diseases") was filed by Travere Therapeutics on Oct 3, 2019. The application was issued on Oct 1, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSJun 30, 2026ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3860594

TRAVERE THERAPEUTICS
Application Number
EP19791401A
Filing Date
Oct 3, 2019
Status
Granted And Under Opposition
Aug 29, 2025
Publication Date
Oct 1, 2025